Vicky Smith promoted to senior account executive at Liberation Unlimited
August 27, 2015Medical Communications Vicki Smith, liberation unlimited
Liberation Unlimited has promoted Vicky Smith to senior account executive.Vicky joined Liberation Unlimited in 2013, and has since played an …
Alvogen buys four-drug portfolio from Pfizer
August 27, 2015Sales and Marketing Alvogen, Pfizer
Alvogen has entered into a agreement with Pfizer to purchase a portfolio of four pharmaceutical products for the US market, …
NHS restriction of CML treatment in England criticised
August 27, 2015Medical Communications, Sales and Marketing NHS, NICE, chronic myeloid leukaemia, leukaemia
Medical experts have criticised NHS cost regulators’ decision to limit the use of Ariad’s Iclusig (ponatinib) in the treatment of …
Immatics and MD Anderson launch new company to develop ACR therapies
August 27, 2015Research and Development, Sales and Marketing Cancer, MD Anderson Cancer Center, immatics, keytruda
Immatics Biotechnologies and The University of Texas MD Anderson Cancer Center (MDACC) have together launched a new company focusing on …
NICE targets tight blood sugar control in new diabetes guidelines
August 27, 2015NICE, NICE guidelines, Public Health England, Type 1 diabetes, diabetes
NICE has urged healthcare professionals to target tighter blood sugar control, in a suite of recommendation in updated guidelines on …
Lilly defeats Teva in US court over Alimta patent
August 26, 2015Research and Development, Sales and Marketing Alimta, Eli Lilly, Teva Pharmaceutical, lung cancer
Eli Lilly has won a case in a US federal court, in a battle over Teva’s attempt to create a …
Novo Nordisk plans $2bn expansion of production facilities
August 26, 2015Manufacturing and Production, Research and Development Novo Nordisk, manufacturing
Novo Nordisk will invest an estimated $2 billion over the next five years in new production facilities in the US, …
After the legal case – where next for pharma industry transparency?
August 26, 2015Research and Development clinical trial transparency, clinical trials, health research authority, transparency
Even in an industry as litigious as pharma can sometimes be, the recent legal drama that has played out in …
Novo Nordisk abandons Victoza submission after mixed T1D results
August 26, 2015Research and Development Novo Nordisk, Victoza, diabetes, insulin
Novo Nordisk has been forced to scrap plans to expand its licence for Victoza to include adults with type 1 …
Researchers hopeful experimental antiviral treatment stops Ebola
August 26, 2015Research and Development Ebola, Ebola virus, Ebola virus disease, Toyama Chemical, VSV-ZEBOV, favipiravir, zmapp
An experimental antiviral therapy may have prevented British healthcare workers from contracting Ebola after exposure to the disease in West …
Lilly and Boehringer launch biosimilar insulin in the UK
August 26, 2015Manufacturing and Production, Research and Development, Sales and Marketing Boehringer, Boehringer Ingelheim, Eli Lilly, Lantus, abasaglar, basal insulin, biosimilar, biosimilars, diabetes, insuling glargine, lilly
Lilly and Boehringer Ingelheim have launched their biosimilar insulin, called abasaglar, for the UK market. Abasaglar will now challenge the …
TSRI and Janssen close in on universal flu vaccine
August 25, 2015Manufacturing and Production Janssen, Vaccine, flu, immunology, universal flu vaccine
Scientists from Janssen and The Scripps Research Institute (TSRI) have found a way to induce antibodies to fight a wide …
Allergan recalls eye drugs after complaints of blurred vision
August 25, 2015Manufacturing and Production Allergan, manufacturing, product recalls, production, recalls
Allergan has issued a recall for batches of eye ointments sold in the US, after customers complained of foreign bodies …
Takeda in Velcade patent blow
August 25, 2015Manufacturing and Production Actavis, Sandoz, Takeda, Velcade, bortezomib, ixazomib
Takeda has lost a court case contesting the patent for its blockbuster multiple myeloma drug Velcade, in a decision that …
AZ appoints Genentech’s Sean Bohen as chief medical officer
August 25, 2015Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Briggs Morrison, Sean Bohen
AstraZeneca has appointed Dr Sean Bohen as executive vice president of global medicines development and chief medical officer.Dr Bohen will …
Clinical Trial Transparency – A Personal View
August 24, 2015Research and Development ABPI, PMCPA, clinical trial transparency, clinical trials, health research authority, transparency
During the time I worked as research, medical and innovation director at the ABPI, between October 2012 and January 2015, …
AstraZeneca cancer drug trialled for pancreatic cancer
August 24, 2015Research and Development
AstraZeneca is working with the Banner MD Anderson Cancer Center in Arizona to test its cancer drug Lynparza as a …
AstraZeneca and Peregrine in immuno-oncology collaboration
August 24, 2015Research and Development AstraZeneca, Cancer, MEDI4736, Peregrine, Peregrine Pharmaceuticals, bavituximab, durvalumab, immunoncology, immunotherapy, oncology, tumours
AstraZeneca and Peregrine Pharmaceuticals will collaborate on a clinical trial to test two of the companies’ cancer treatments. The Phase …
Doctors ‘face jail over pharma payments’
August 24, 2015Sales and Marketing ABPI, Jeremy Hunt, NHS, PMCPA, bribery, doctor payments, health secretary, transparency
Healthcare professionals who have inappropriate financial links with pharma companies will face prosecution and up to 10 years in jail, …
Takeda gets European MAA approval for ixazomib
August 21, 2015Medical Communications, Research and Development (FDA/EMA/MHRA), FDA/EMA/MHRA, Takeda, ixazomib, multiple myeloma
Takeda has announced that the European Medicines Agency (EMA) has accepted its Marketing Authorisation Application (MAA) for ixazomib, an investigational …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
